News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McDevitt Damien
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 8,709 shares
@ $18.12, valued at
$157.8k
|
|
| 09/02/2020 |
4
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 1,104 shares
@ $14.399, valued at
$15.9k
|
|
| 03/31/2020 |
4/A
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 60,000 shares
@ $0
Granted 120,000 options to buy
@ $12.76, valued at
$1.5M
|
|
| 03/25/2020 |
4
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 9,417 shares
@ $11.7499, valued at
$110.6k
|
|
| 03/23/2020 |
4
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 55,200 shares
@ $0
Granted 109,800 options to buy
@ $12.76, valued at
$1.4M
Granted 200,000 options to buy
@ $12.76, valued at
$2.6M
|
|
| 09/23/2019 |
4
| McDevitt Damien (Interim Chief Executive Office) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 200,000 shares
@ $0
Granted 400,000 options to buy
@ $22.46, valued at
$9M
|
|
| 07/17/2019 |
4
| McDevitt Damien (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,225 shares
@ $67.86, valued at
$83.1k
Exercised 3,542 restricted stock units
@ $0 |
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2019 |
4
| McDevitt Damien (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 13,065 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| McDevitt Damien (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 29,400 options to buy
@ $53.77, valued at
$1.6M
|
|
| 10/11/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/16/2018 |
4
| McDevitt Damien (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 14,167 restricted stock units
@ $0 |
|
| 06/18/2018 |
4
| McDevitt Damien (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 63,750 options to buy
@ $43.6, valued at
$2.8M
|
|
| 06/18/2018 |
3
| McDevitt Damien (Chief Business Officer) has filed a Form 3 on IONIS PHARMACEUTICALS INC |
|
|